Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping (Q37202877)

18 August 2017

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping (English)

1 reference

18 August 2017

1 reference

Jonathan S. Schildcrout

1

object named as

J S Schildcrout

1 reference

18 August 2017

11

M D Ritchie

1 reference

18 August 2017

J C Denny

2

1 reference

18 August 2017

E Bowton

3

1 reference

18 August 2017

W Gregg

4

1 reference

18 August 2017

J M Pulley

5

1 reference

18 August 2017

M A Basford

6

1 reference

18 August 2017

J D Cowan

7

1 reference

18 August 2017

H Xu

8

1 reference

18 August 2017

A H Ramirez

9

1 reference

18 August 2017

D C Crawford

10

1 reference

18 August 2017

J F Peterson

12

1 reference

18 August 2017

D R Masys

13

1 reference

18 August 2017

R A Wilke

14

1 reference

18 August 2017

D M Roden

15

1 reference

18 August 2017

language of work or name

English

0 references

publication date

27 June 2012

1 reference

Clinical Pharmacology & Therapeutics

18 August 2017

1 reference

18 August 2017

92

1 reference

18 August 2017

2

1 reference

18 August 2017

235-242

1 reference

Predicting clopidogrel response using DNA samples linked to an electronic health record.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Electronic medical records for genetic research: results of the eMERGE consortium

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Assessing the accuracy of observer-reported ancestry in a biorepository linked to electronic medical records

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Cost-effectiveness of zoledronic acid plus endocrine therapy in premenopausal women with hormone-responsive early breast cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

The Path to Personalized Medicine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

MedEx: a medication information extraction system for clinical narratives.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Estimation of the warfarin dose with clinical and pharmacogenetic data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

SLCO1B1 variants and statin-induced myopathy--a genomewide study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Development of a large-scale de-identified DNA biobank to enable personalized medicine.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

HLA-B*5701 screening for hypersensitivity to abacavir

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Construction of atorvastatin dose-response relationships using data from a large population-based DNA biobank

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Pharmacogenetics and pharmacogenomics: development, science, and translation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Weighing the benefits of high-dose simvastatin against the risk of myopathy.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Hospitalization costs associated with warfarin-related bleeding events among older community-dwelling adults

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Opportunities and challenges for the NIH--an interview with Francis Collins. Interview by Robert Steinbrook.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Multi-mutational analysis of fifteen common mutations of the glucose 6-phosphate dehydrogenase gene in the Mediterrranean population.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785311

Nonparametric Estimation from Incomplete Observations

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FCLPT.2012.66

Pharmacogenomics at the tipping point: challenges and opportunities

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22739144

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Nature of Hemolytic Crises and the Fate of G6PD Deficient, Drug-Damaged Erythrocytes in Sardinians

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22739144

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22739144

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/CLPT.2012.66

1 reference

18 August 2017

1 reference

18 August 2017

1 reference